Insight Molecular Diagnostics
IMDX · Irvine, CA
Works in Oncology · Respiratory
Insight Molecular Diagnostics is a clinical trial sponsor based in Irvine, CA, listed as IMDX. It has 2 active clinical trials with 5,125 planned participants, in Oncology and Respiratory. Since 2021 it has completed 0 trials and stopped 1 early.
Trial track record · since 2021
Financials · IMDX
Fundraising
Pipeline · 2 active trials
| Stage | Trial | Status |
|---|---|---|
Questions about Insight Molecular Diagnostics
Insight Molecular Diagnostics is lead sponsor of 2 active clinical trials on ClinicalTrials.gov, with 5,125 planned participants, in Oncology, Respiratory. Since 2021 it has completed 0 trials and stopped 1 early.
Insight Molecular Diagnostics is based in Irvine, CA and is listed as IMDX. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Insight Molecular Diagnostics; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-07-30.
Approve Suite is not affiliated with Insight Molecular Diagnostics.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.